Nexien BioPharma, Inc.
OTC: NXEN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Richard S. Greenberg
- Headquarters
- Glendale, United States
- IPO year
- 2017
- Market cap
- $7.1K
- Website
- https://www.nexienbiopharma.com
Loading NXEN…
Loading profile data…Frequently asked questions about NXEN
What does Nexien BioPharma, Inc. (NXEN) do?
Nexien BioPharma, Inc., a pharmaceutical firm headquartered in Glendale, Colorado, concentrates its efforts on the research, advancement, and market introduction of cannabinoid-derived medications. The company utilizes both pre-clinical and clinical development paths to address a variety of diseases, medical conditions, and disorders. It adopted...
Where does NXEN trade?
Nexien BioPharma, Inc. (NXEN) trades on the Other OTC.
What sector is NXEN in?
Nexien BioPharma, Inc. (NXEN) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Nexien BioPharma, Inc.?
Richard S. Greenberg is the chief executive officer of Nexien BioPharma, Inc. (NXEN).
Where is Nexien BioPharma, Inc. headquartered?
Nexien BioPharma, Inc. is headquartered in United States.
Does NXEN pay a dividend?
Nexien BioPharma, Inc. (NXEN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NXEN go public?
Nexien BioPharma, Inc. (NXEN) completed its initial public offering in 2017.